Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 84

Sort by

Sort Order Select

Journal Articles

Next-Generation FVIII Mimetic Shows Superior Effect in a FIX- and Fx-Humanized Mouse Model In Vivo

Carsten Dan Ley, PhD, Thomas Lindebo Holm, PhD, Daniel Elenius, PhD, Heidi Lindgreen Holmberg, PhD, Jais Rose Bjelke, PhD, Mette Loftager, PhD, Mette B Hermit, PhD, Ida Hilden, Stine L Kjellev, PhDDVM

Blood (2019) 134 (Supplement_1): 3631.

https://doi.org/10.1182/blood-2019-128159

Published: 2019

Journal Articles

Exposure-Response of Quizartinib Efficacy in Patients with Relapsed/Refractory AML

Dongwoo Kang, PhD, Julie Passarell, MA, Malaz A Abutarif, PhD, Jeanne Mendell, PhD MPH, Ophelia Yin, PhD

Blood (2019) 134 (Supplement_1): 1263.

https://doi.org/10.1182/blood-2019-122582

Published: 2019

Journal Articles

Pilot Study of Oral Realgar-Indigo Naturalis Formula in Pediatric Acute Promyelocyticleukemia: Effectiveness and Population Pharmacokinetics

Li Zhang, Xin-mei Yang, Jing Chen, Lei Hu, Fan Yang, Yue Zhou, Bei-bei Zhao, Wei Zhao, Xiao-fan Zhu, PhD

Blood (2019) 134 (Supplement_1): 5084.

https://doi.org/10.1182/blood-2019-122876

Published: 2019

Journal Articles

Myeloma Cells Have the Ability to Suppress Th1-Inducing Capacity but Enhance Th2-Mediated Response of Dendritic Cells By Producing Factors Other Than Soluble SLAMF7

Yoshiko Azuma, MD, Tomoki Ito, MD PhD, Muneo Inaba, PhD, Kai Imai, MD, Hideaki Yoshimura, MD, Masaaki Hotta, MD, Takahisa Nakanishi, MD PhD, Shinya Fujita, MD PhD, Aya Nakaya, MD PhD, Atsushi Satake, MD PhD, Kazuyoshi Ishii, MDMPH,PhD, Shosaku Nomura, MD PhD

Blood (2018) 132 (Supplement 1): 1938.

https://doi.org/10.1182/blood-2018-99-113282

Published: 2018

Journal Articles

Correlation of Circulating Microparticles with Coagulation and Fibrinolysis Is Healthy Individuals

Venencia Albert, PhD BSc, MSc, Arulselvi Subramanian, MDpathology, Hara Prasad Pati, MD

Blood (2018) 132 (Supplement 1): 4975.

https://doi.org/10.1182/blood-2018-99-120371

Published: 2018

Journal Articles

Phe174-Mutated Human Factor X As Bypassing Agent to the Direct FXa Inhibitors

Mark Schreuder, MD, Daniel Verhoef, MSc, Ka Lei Cheung, Koen Visscher, MSc, Daan Geerke, PhD, Pieter H. Reitsma, PhD, Mettine H.A. Bos, PhD

Blood (2017) 130 (Supplement 1): 363.

https://doi.org/10.1182/blood.V130.Suppl_1.363.363

Published: 2017

Journal Articles

Lenalidomide and Dexamethasone Therapy in Elderly Patients with Newly Diagnosed Multiple Myeloma to Determine Optimal Plasma Concentration of Lenalidomide

Takahiro Kobayashi, MD, Masatomo Miura, Takenori Niioka, Yuki Fujioka, Maiko Abumiya, Tomoko Yoshioka, Yoshihiro Kameoka, Hiroyoshi Nishikawa, Naoto Takahashi

Blood (2017) 130 (Supplement 1): 3846.

https://doi.org/10.1182/blood.V130.Suppl_1.3846.3846

Published: 2017

Journal Articles

Monitoring Voriconazole Pharmacogenomics and Plasma Concentrations in the Treatment and Prevention of Invasive Fungal Disease for Chinese Hematological Patients

XiaoWen Tang, MD, Honglan Qu, Dandan Guo, Ting Xu, Haiping Dai, Zheng Li, Jia Yin, Xiaopeng Tian, Danqing Guo, Yang Xu, MD PhD, Xiaming Zhu, Liyan Miao, Depei Wu, MD

Blood (2017) 130 (Supplement 1): 4827.

https://doi.org/10.1182/blood.V130.Suppl_1.4827.4827

Published: 2017

Journal Articles

Nrf2 Activation Attenuates Hemolysis but Promotes Pulmonary Vascular Dysfunction in Sickle Mice

Chibueze A. Ihunnah, PhD, Samit Ghosh, PhD, Scott A. Hahn, MS, Adam C Straub, PhD, Solomon F Ofori-Acquah, PhD

Blood (2016) 128 (22): 1296.

https://doi.org/10.1182/blood.V128.22.1296.1296

Published: 2016

Journal Articles

Are Direct Oral Anticoagulants Plasma Concentrations Associated with the Risk of Postoperative Bleeding? Results from the Real Life Cohort

Pável Olivera, MD, Vicente Cortina, Verónica Pons, MD, Tania Canals, MD, Erik Johansson, MD, Francesc Bosch, MD PhD, Amparo Santamaría, MD PhD

Blood (2016) 128 (22): 3819.

https://doi.org/10.1182/blood.V128.22.3819.3819

Published: 2016

Journal Articles

A Chemical APC Mimetic Protects Endothelium from Thromboinflammatory Injury

Karen E.P. De Ceunynck, PhD, Christian G. Peters, PhD, Sharjeel A. Chaudhry, B.S., Abhishek Jain, PhD, Sarah J. Higgins, PhD, Omozuanvbo Aisiku, PhD, Jennifer Fitch-Tewfik, PhD, Christopher Dockendorff, PhD, Samir Parikh, MD PhD, Donald E. Ingber, PhD, Robert C. Flaumenhaft, MD PhD

Blood (2016) 128 (22): 3835.

https://doi.org/10.1182/blood.V128.22.3835.3835

Published: 2016

Journal Articles

Comprehensive Analysis of Safety: Rigosertib in 557 Patients with Myelodysplastic Syndromes (MDS) and Acute Myeloid Leukemia (AML)

Guillermo Garcia-Manero, MD, Pierre Fenaux, MD PhD, Aref Al-Kali, MD, Shyamala C. Navada, MD, Maria R. Baer, MD, Azra Raza, MD, Peter Greenberg, MD, Karl-Anton Kreuzer, MD, Devendra K Hiwase, MBBS, MD FRACP, FRCPA, PhD, Gail J. Roboz, Valeria Santini, MD, Uwe Platzbecker, MD, Michael E. Petrone, MD MPH, Bernard Brownstein, MD, Patrick Simon Zbyszewski, MBA, Manoj Maniar, PhD, Lewis R. Silverman, MD

Blood (2016) 128 (22): 2011.

https://doi.org/10.1182/blood.V128.22.2011.2011

Published: 2016

Journal Articles

Procoagulant Profile in Patients with Immune Thrombocytopaenia

Nora Butta, PhD, Ihosvany Fernandez Bello, PhD, María Teresa Álvarez Román, PhD, María Isabel Rivas Pollmar, Miguel Canales, Victor Jiménez Yuste, PhD

Blood (2015) 126 (23): 1062.

https://doi.org/10.1182/blood.V126.23.1062.1062

Published: 2015

Journal Articles

Prediction of the Lenalidomide Toxicity and Its Therapeutic Efficacy in Japanese Multiple Myeloma Patients By Measuring Its Plasma Concentration.

Yoko Kado, BS, Fumiaki Kitazawa, MS, Masayuki Tsujimoto, PhD, Shin-ichi Fuchida, MD PhD, Akira Okano, MD PhD, Mayumi Hatsuse, MD, Satoshi Murakami, MD, Kumi Ueda, BS, Takatoshi Kokufu, BS, Shoichi Ozawa, Natsuko Ito, Satoe Morishita, Tetsuya Takada, BS, Tetsuya Minegaki, PhD, Kohshi Nishiguchi, PhD, Eishi Ashihara, MD PhD, Chihiro Shimazaki, MD PhD

Blood (2015) 126 (23): 3700.

https://doi.org/10.1182/blood.V126.23.3700.3700

Published: 2015

Journal Articles

Clinical and Correlative Results of a Phase 1 Study of Cerdulatinib (PRT062070) a Dual SYK/JAK Inhibitor in Patients with Relapsed/Refractory B Cell Malignancies

Paul A Hamlin, Jr., MD, Ian Flinn, MD, Nina wagner-Johnston, MD, Jan A Burger, MD PhD, Glenn Michelson, MD, Anjali Pandey, PhD, Matt Birrell, Greg P. Coffey, PhD, Janet M Leeds, PhD, John T. Curnutte, MDPhD, Manish R. Patel, MD

Blood (2015) 126 (23): 3929.

https://doi.org/10.1182/blood.V126.23.3929.3929

Published: 2015

Journal Articles

Development of a New Automated Assay for Measurement of the Oral Direct Factor Xa Inhibitor Edoxaban Plasma Concentration

Tristan Herve, Sandra Beaufils, Jarema Kochan, Ling He, Francois Depasse

Blood (2014) 124 (21): 2870.

https://doi.org/10.1182/blood.V124.21.2870.2870

Published: 2014

Journal Articles

Clarithromycin Elevates the Plasma Concentration of Lenalidomide Via Inhibition of MDR1

Naoki Takezako, MD PhD, Masatomo Miura, PhD, Akihisa Nagata, MD PhD, Naohiro Sekiguchi, MD PhD, Takenori Niioka, PhD, Seiji Shida, MD, Takahiro Kobayashi, MD, Maiko Abumiya, Akiyoshi Miwa, MD PhD, Naoto Takahashi, MD PhD

Blood (2014) 124 (21): 3479.

https://doi.org/10.1182/blood.V124.21.3479.3479

Published: 2014

Journal Articles

Preclinical and Clinical Pharmacodynamics of Pan-Pim Inhibition By AZD1208 in Acute Myeloid Leukemia: Assessment of Pim Isoform Dependency for Bad and 4EBP1 Phosphorylation

Kristen A McEachern, PhD, Adriana E Tron, PhD, Greg O'Connor, Rachel DuPont, Francis D Gibbons, PhD, Lourdes Pablo, Karthick Vishwanathan, PhD, Patricia McCoon, PhD, Jorge E. Cortes, MD, Daniel J. DeAngelo, MDPhD, Mark D Minden, MDPhD, Geoffrey L. Uy, MD, Frank Neumann, MDPhD, Karen Keating, Dennis Huszar, PhD, J. Elizabeth Pease, PhD, Jeffrey Brown, PhD, J. Carl Barrett, PhD

Blood (2014) 124 (21): 906.

https://doi.org/10.1182/blood.V124.21.906.906

Published: 2014

Journal Articles

Estimation of Dabigatran Plasma Concentrations in the Perioperative Setting. an Ex-Vivo Study Using Dedicated Coagulation Assays

Jonathan Douxfils, Pharm D, PhDStudent, Sarah Lessire, MDcal Doctor and PhDstudent, Anne-Sophie Dincq, MDcal Doctor, Maximilien Gourdin, Professor, Damien Gheldof, PhDStudent, Justine Baudar, Bernard Chatelain, Professor, Jean-Michel Dogné, Professor, François Mullier, Professor

Blood (2014) 124 (21): 1549.

https://doi.org/10.1182/blood.V124.21.1549.1549

Published: 2014

Journal Articles

The Measure of Plasma Concentrations Is Crucial in Managing Dabigatran Treatment in Non-Valvular Atrial Fibrillation

Diana Iosub, MD, Rosa Trotti, MD, Franco Piovella, MD

Blood (2014) 124 (21): 5088.

https://doi.org/10.1182/blood.V124.21.5088.5088

Published: 2014

NARROW

Next-Generation FVIII Mimetic Shows Superior Effect in a FIX- and Fx-Humanized Mouse Model In Vivo

Exposure-Response of Quizartinib Efficacy in Patients with Relapsed/Refractory AML

Pilot Study of Oral Realgar-Indigo Naturalis Formula in Pediatric Acute Promyelocyticleukemia: Effectiveness and Population Pharmacokinetics

Myeloma Cells Have the Ability to Suppress Th1-Inducing Capacity but Enhance Th2-Mediated Response of Dendritic Cells By Producing Factors Other Than Soluble SLAMF7

Correlation of Circulating Microparticles with Coagulation and Fibrinolysis Is Healthy Individuals

Phe174-Mutated Human Factor X As Bypassing Agent to the Direct FXa Inhibitors

Lenalidomide and Dexamethasone Therapy in Elderly Patients with Newly Diagnosed Multiple Myeloma to Determine Optimal Plasma Concentration of Lenalidomide

Monitoring Voriconazole Pharmacogenomics and Plasma Concentrations in the Treatment and Prevention of Invasive Fungal Disease for Chinese Hematological Patients

Nrf2 Activation Attenuates Hemolysis but Promotes Pulmonary Vascular Dysfunction in Sickle Mice

Are Direct Oral Anticoagulants Plasma Concentrations Associated with the Risk of Postoperative Bleeding? Results from the Real Life Cohort

A Chemical APC Mimetic Protects Endothelium from Thromboinflammatory Injury

Comprehensive Analysis of Safety: Rigosertib in 557 Patients with Myelodysplastic Syndromes (MDS) and Acute Myeloid Leukemia (AML)

Procoagulant Profile in Patients with Immune Thrombocytopaenia

Prediction of the Lenalidomide Toxicity and Its Therapeutic Efficacy in Japanese Multiple Myeloma Patients By Measuring Its Plasma Concentration.

Clinical and Correlative Results of a Phase 1 Study of Cerdulatinib (PRT062070) a Dual SYK/JAK Inhibitor in Patients with Relapsed/Refractory B Cell Malignancies

Development of a New Automated Assay for Measurement of the Oral Direct Factor Xa Inhibitor Edoxaban Plasma Concentration

Clarithromycin Elevates the Plasma Concentration of Lenalidomide Via Inhibition of MDR1

Preclinical and Clinical Pharmacodynamics of Pan-Pim Inhibition By AZD1208 in Acute Myeloid Leukemia: Assessment of Pim Isoform Dependency for Bad and 4EBP1 Phosphorylation

Estimation of Dabigatran Plasma Concentrations in the Perioperative Setting. an Ex-Vivo Study Using Dedicated Coagulation Assays

The Measure of Plasma Concentrations Is Crucial in Managing Dabigatran Treatment in Non-Valvular Atrial Fibrillation

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only